Showing posts with label Liver. Show all posts
Showing posts with label Liver. Show all posts

Thursday, 2 April 2020

Oncology Nutrition Market worth $2.21 Billion by 2023 – Exclusive Report by MarketsandMarkets™


According to the new market research report “Oncology Nutrition Market by Cancer Type (Head & Neck, Stomach & Gastrointestinal, Liver, Pancreatic, Esophageal, Lung, Breast, Blood) - Global Forecast to 2023", published by MarketsandMarkets™, The oncology nutrition market was valued at USD 1.34 Billion in 2017 and is expected to reach USD 2.21 Billion by 2023, at a CAGR of 8.7% during the forecast period.

Factors such as the development of elemental formulas and product innovation in terms of non-GMO-based formulas present significant opportunities for the growth of oncology-based nutrition

Access Free Sample Research Copy: https://www.marketsandmarkets.com/requestsampleNew.asp?id=166703967
          


“The study answers several questions for stakeholders, primarily which market segments to focus in the next five years for prioritizing efforts & investments and competitive landscape of the market.”

Oncology Nutrition Market segmented into :

> The report analyzes the oncology nutrition market by type of cancer and region. Based on cancer type, the head and neck cancers segment accounted for the largest share of the market in 2017. Patients with head and neck cancers suffer from severe problems associated with oral nutritional intake.
> Thus, the enteral route is used for nutrition support. With the increasing number of such cancers cases, the uptake of tube feeding formulas has increased. Also, conditions such as severe mucositis, xerostomia, dysgeusia, and nausea & vomiting limit nutritional intake, adding to the adoption of oncology nutritional feeding formulas.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=166703967

Geographical Growth Analysis:

Geographically, the oncology nutrition market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. In 2017, North America accounted for the largest share of this market. However, the Asia Pacific region is expected to witness the highest CAGR during the forecast period of 2018 to 2023. The growth of this segment can be attributed to the increased awareness and accessibility to advanced healthcare facilities, rising healthcare spending, large population base, and rapid improvements in the health insurance sector.

Key Players and Strategies Adopted by Them:

Abbott Laboratories (US), Nestle S.A. (Switzerland), Danone (France), Fresenius Kabi AG (Germany), and B.Braun Melsungen AG (Germany). The other players in this market include Mead Johnson Nutrition Company (US), Hormel Foods (US), Meiji Holdings (Japan), Victus (US), and Global Health Products (US).

Speak to Analyst @ https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=166703967

Wednesday, 4 March 2020

Oncology Nutrition Market | Analysis of Worldwide Industry Trends and Opportunities


According to the new market research report “Oncology Nutrition Market by Cancer Type (Head & Neck, Stomach & Gastrointestinal, Liver, Pancreatic, Esophageal, Lung, Breast, Blood) - Global Forecast to 2023", published by MarketsandMarkets™, The oncology nutrition market was valued at USD 1.34 Billion in 2017 and is expected to reach USD 2.21 Billion by 2023, at a CAGR of 8.7% during the forecast period.

Factors such as the development of elemental formulas and product innovation in terms of non-GMO-based formulas present significant opportunities for the growth of oncology-based nutrition formulas.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=166703967

                    
The report analyzes the oncology nutrition market by type of cancer and region. Based on cancer type, the head and neck cancers segment accounted for the largest share of the market in 2017. Patients with head and neck cancers suffer from severe problems associated with oral nutritional intake. Thus, the enteral route is used for nutrition support. With the increasing number of such cancers cases, the uptake of tube feeding formulas has increased. Also, conditions such as severe mucositis, xerostomia, dysgeusia, and nausea & vomiting limit nutritional intake, adding to the adoption of oncology nutritional feeding formulas.

Browse and in-depth TOC on " Oncology Nutrition Market "
11 – Tables
23 - Figures
92 - Pages

Oncology Nutrition Market segmented into :

> The report analyzes the oncology nutrition market by type of cancer and region. Based on cancer type, the head and neck cancers segment accounted for the largest share of the market in 2017. Patients with head and neck cancers suffer from severe problems associated with oral nutritional intake.
> Thus, the enteral route is used for nutrition support. With the increasing number of such cancers cases, the uptake of tube feeding formulas has increased. Also, conditions such as severe mucositis, xerostomia, dysgeusia, and nausea & vomiting limit nutritional intake, adding to the adoption of oncology nutritional feeding formulas.

Get Sample Copy of This Report
@https://www.marketsandmarkets.com/requestsampleNew.asp?id=166703967

Geographical Growth Analysis:

Geographically, the oncology nutrition market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. In 2017, North America accounted for the largest share of this market. However, the Asia Pacific region is expected to witness the highest CAGR during the forecast period of 2018 to 2023. The growth of this segment can be attributed to the increased awareness and accessibility to advanced healthcare facilities, rising healthcare spending, large population base, and rapid improvements in the health insurance sector.

Thursday, 30 January 2020

Oncology Nutrition Market worth 2.21 Billion USD by 2023


According to the new market research report "Oncology Nutrition Market by Cancer Type (Head & Neck, Stomach & Gastrointestinal, Liver, Pancreatic, Esophageal, Lung, Breast, Blood) - Global Forecast to 2023", published by MarketsandMarkets™, analyzes and studies the major market drivers, restraints/challenges, and opportunities in North America, Europe, Asia-Pacific, and the Rest of the world (RoW).

Don’t miss out on business opportunities in Oncology Nutrition Market.
Speak to our analyst and gain crucial industry insights that will help your business grow: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=166703967

                              

Factors such as the shift from parenteral to enteral nutrition along with the increasing incidence of cancer, growing demand for nutritional feeding in the homecare sector, rising number of patients being treated for malnutrition, and increasing quality of clinical research on nutritional interventions are driving the growth of the oncology nutrition market.

Furthermore, the development of elemental formulas and product innovation in terms of non-GMO-based formulas present significant opportunities for the growth of excipients. However, the complications associated with tube feeding and limited reimbursements represent a significant challenge to the market growth. The oncology nutrition market is expected to reach USD 2.21 Billion by 2023 from an estimated USD 1.46 Billion in 2018, at a CAGR of 8.7% during the forecast period.

Browse and in-depth TOC on " Oncology Nutrition Market "
11 – Tables
23 - Figures
92 - Pages
Request for Sample Report @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=166703967

Based on type of cancer, the head and neck cancers segment accounted for the largest share of the oncology nutrition market, in 2017. This can be attributed to the use of tube feeding formulas for patients with head and neck cancers as conditions such as severe mucositis, xerostomia, dysgeusia, and nausea & vomiting in these patients limits nutritional intake.

Download an Illustrative overview of the report @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=166703967

North America accounted for the largest share of the oncology nutrition market in 2017, followed by Europe. This regional segment shows significant market growth owing to the increasing prevalence of chronic diseases and disorders, coupled with rapidly growing aging population, which shows greater susceptibility to chronic and acute disorders than other population segments. In addition, long-term care facilities such as homecare & hospices, nursing homes, and assisted living facilities have emerged as efficient alternatives to hospitals. Furthermore, owing to cost-cutting pressures in hospitals, the healthcare system has seen a shift from extended hospital treatment to treatment at home, which is expected to propel the demand for such feeding formulas.

The prominent players in the oncology nutrition market are Abbott Laboratories (US), Nestle S.A. (Switzerland), Danone (France), Fresenius Kabi AG (Germany), and B. Braun Melsungen AG (Germany).

Friday, 7 June 2019

Transplant Diagnostics Market Size, Industry Analysis, Share, Growth | MarketsandMarkets™


According to the new market research report " HLA Typing for Transplant Market by Technology (SSO-PCR, SSP-PCR, NGS, Sanger’s Sequencing), Products & Services (Instruments, Reagents, Software), Application (Diagnostics, Research), End User (Hospitals, Academia, Diagnostic Center) - Forecast to 2021", published by MarketsandMarkets™,The global HLA typing for transplant market is projected to reach USD 753.9 Million by 2021 from USD 535.0 Million in 2016, at a CAGR of 7.1% from 2016 to 2021.


Don’t miss out on business opportunities in Transplant Diagnostics Market

Browse and in-depth TOC on "Transplant Diagnostics Market"
60  - Figures
203 - Pages

 Market growth can be attributed to factors such as the rising number of solid organ, soft tissue, and stem cell transplantations; technological advancements in the field of organ transplantation; increased funding, research grants, and public-private investments; technological shift from serological assays to gene-based HLA profiling; and improving healthcare infrastructure across developing countries.
To know about the assumptions considered for the study, download the pdf brochure
Scope of the Report
This research report categorizes the HLA typing for transplant market into the following segments and sub segments:
HLA Typing for Transplant Market, By Technology
·         Non-Molecular Assay
§  Serological Assay
§  Mixed Lymphocyte Culture Assay (MLC Assay)
·         Molecular Assay
§  PCR-based
o   Sequence specific primer-PCR (SSP-PCR)
o   Sequence specific oligonucleotide-PCR (SSO-PCR)
·         Sequencing-based
§  Next Generation Sequencing
§  Sanger’s Sequencing

Please click here to get the global report of Transplant Diagnostics Market by Technology (PCR, SSO-PCR, SSP-PCR, NGS, Sanger’s Sequencing, Microarray), Products & Services (Instruments, Reagents), Application (Blood Profiling, Infectious Disease Testing), End User (Hospitals) - Global forecast 2021

The global HLA typing for transplant market is projected to reach USD 753.9 Million by 2021 from USD 535.0 Million in 2016, growing at a CAGR of 7.1% from 2016 to 2021. Market growth can be attributed to factors such as the rising number of solid organ, soft tissue, and stem cell transplantations; technological advancements in the field of organ transplantations; and increased funding, research grants, and public-private investments. However, the high device costs associated with NGS and PCR-based devices and limited medical reimbursements for organ donation and transplantation procedures restrain the optimal growth of the HLA typing for transplant market. 

To speak to our analyst for a discussion on the above findings, click Speak to Analyst